Benedetti MD - Search Results

1

Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.

Gajofatto A, Turatti M, Monaco S, Benedetti MD. Gajofatto A, et al. Among authors: benedetti md. Drug Healthc Patient Saf. 2015 Dec 11;7:157-67. doi: 10.2147/DHPS.S69640. eCollection 2015. Drug Healthc Patient Saf. 2015. PMID: 26715860 Free PMC article. Review.

2

Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro.

Moretto G, Monaco S, Passarin MG, Benedetti MD, Rizzuto N. Moretto G, et al. Among authors: benedetti md. Arch Toxicol. 1991;65(5):409-13. doi: 10.1007/BF02284265. Arch Toxicol. 1991. PMID: 1929857

3

Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients.

Zanusso G, Fiorini M, Farinazzo A, Gelati M, Benedetti MD, Ferrari S, Dalla Libera A, Capaldi S, Monaco HL, Rizzuto N, Monaco S. Zanusso G, et al. Among authors: benedetti md. Neurology. 2005 May 10;64(9):1618-20. doi: 10.1212/01.WNL.0000160397.81314.84. Neurology. 2005. PMID: 15883327

4

Azathioprine in multiple sclerosis.

Invernizzi P, Benedetti MD, Poli S, Monaco S. Invernizzi P, et al. Among authors: benedetti md. Mini Rev Med Chem. 2008 Aug;8(9):919-26. doi: 10.2174/138955708785132756. Mini Rev Med Chem. 2008. PMID: 18691149 Review.

5

Long survival and clinical stability in Marburg's variant multiple sclerosis.

Turatti M, Gajofatto A, Rossi F, Vedovello M, Benedetti MD. Turatti M, et al. Among authors: benedetti md. Neurol Sci. 2010 Dec;31(6):807-11. doi: 10.1007/s10072-010-0287-4. Epub 2010 May 12. Neurol Sci. 2010. PMID: 20461429

6

Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases.

Gajofatto A, Monaco S, Fiorini M, Zanusso G, Vedovello M, Rossi F, Turatti M, Benedetti MD. Gajofatto A, et al. Among authors: benedetti md. Arch Neurol. 2010 Jun;67(6):724-30. doi: 10.1001/archneurol.2010.107. Arch Neurol. 2010. PMID: 20558391

7

Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis.

Fiorini M, Zanusso G, Benedetti MD, Righetti PG, Monaco S. Fiorini M, et al. Among authors: benedetti md. Proteomics Clin Appl. 2007 Sep;1(9):963-71. doi: 10.1002/prca.200700091. Epub 2007 Aug 10. Proteomics Clin Appl. 2007. PMID: 21136750

8

Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score.

Invernizzi P, Bertolasi L, Bianchi MR, Turatti M, Gajofatto A, Benedetti MD. Invernizzi P, et al. Among authors: benedetti md. J Neurol. 2011 Nov;258(11):1933-9. doi: 10.1007/s00415-011-6033-x. Epub 2011 Apr 9. J Neurol. 2011. PMID: 21479648

9

Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?

Gajofatto A, Bongianni M, Zanusso G, Benedetti MD, Monaco S. Gajofatto A, et al. Among authors: benedetti md. Int J Mol Sci. 2011;12(11):7960-70. doi: 10.3390/ijms12117960. Epub 2011 Nov 16. Int J Mol Sci. 2011. PMID: 22174643 Free PMC article. Review.

10

Prognostic factors of acute partial transverse myelitis.

Gajofatto A, Benedetti MD. Gajofatto A, et al. Among authors: benedetti md. Arch Neurol. 2012 Nov;69(11):1523; author reply 1523-4. doi: 10.1001/archneurol.2012.2302. Arch Neurol. 2012. PMID: 23117920 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page